Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

29.01.2019 | case report | Ausgabe 2/2019

memo - Magazine of European Medical Oncology 2/2019

Solitary scalp metastatic lesion as a sign of breast cancer recurrence—a case report

memo - Magazine of European Medical Oncology > Ausgabe 2/2019
MD Ahmed A. M. Abdelhafeez, MD Wael Ibrahim, MD Wessam Elsherief
Wichtige Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.



Scalp tumors are rare and account only for 2%. Nevertheless, the scalp region accounts for 4–6.9% of all cutaneous metastases. Metastatic cutaneous lesions are more often found in women with breast cancer than in those with other internal malignancies.


Case report.


A 59-year-old woman, who had been clinically diagnosed with stage-IIIA (T3 N2a M0) invasive ductal right breast carcinoma in August 2015, was treated by neoadjuvant chemotherapy with good partial response. Breast conservative surgery was done and she received post-operative adjuvant radiotherapy and hormonal treatment with letrozole. Two years later, the patient noticed a slowly growing, painless scalp nodule. A PET-CT scan was performed and demonstrated scalp mass at the left temporal region. Excisional biopsy was performed; histopathologic examination revealed poorly differentiated adenocarcinoma. In addition, detailed immunohistochemical staining was performed. Accordingly, patient was given radiotherapy and second line hormonal treatment was added, with disease-free survival of one year.


Despite its rarity, solitary scalp metastasis should be considered in the differential diagnosis in patients with a history of cancer especially breast cancer.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 2/2019

memo - Magazine of European Medical Oncology 2/2019 Zur Ausgabe